The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review ; volume:37 ; number:7 ; day:22 ; month:5 ; year:2020 ; pages:3059-3082 ; date:7.2020
Advances in therapy ; 37, Heft 7 (22.5.2020), 3059-3082, 7.2020
- Urheber
-
Rugo, Hope S.
Jacobs, Ira
Sharma, Shikhar
Scappaticci, Frank
Paul, Thomas A.
Jensen-Pergakes, Kristen
Malouf, Gabriel G.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-020-01379-x
- URN
-
urn:nbn:de:101:1-2020082101120336886512
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rugo, Hope S.
- Jacobs, Ira
- Sharma, Shikhar
- Scappaticci, Frank
- Paul, Thomas A.
- Jensen-Pergakes, Kristen
- Malouf, Gabriel G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Histone methyltransferase SETDB1 regulates fetal hematopoiesis
Assay development and inhibitor optimization for the histone lysine methyltransferase KMT9
Histone methyltransferase SMYD2: ubiquitous regulator of disease
Histone methyltransferase and drug resistance in cancers
The histone methyltransferase DOT1L is required for DNA damage recognition and repair
A somatic role for the histone methyltransferase Setdb1 in endogenous retrovirus silencing
Structural insights into a novel histone methyltransferase - KMT9
Histone H3 lysine 4 methyltransferase is required for facultative heterochromatin at specific loci
The promise of Immuno-oncology: implications for defining the value of cancer treatment
Caf1 regulates the histone methyltransferase activity of Ash1 by sensing unmodified histone H3
Functional characterization of histone modifications : survey of novel histone modifications reveals PCMT1 as a new histone methyltransferase
Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma
Histone methyltransferase SETDB1 regulates fetal hematopoiesis
Assay development and inhibitor optimization for the histone lysine methyltransferase KMT9
Histone methyltransferase SMYD2: ubiquitous regulator of disease
Histone methyltransferase and drug resistance in cancers
The histone methyltransferase DOT1L is required for DNA damage recognition and repair
A somatic role for the histone methyltransferase Setdb1 in endogenous retrovirus silencing
Structural insights into a novel histone methyltransferase - KMT9
Histone H3 lysine 4 methyltransferase is required for facultative heterochromatin at specific loci
The promise of Immuno-oncology: implications for defining the value of cancer treatment
Caf1 regulates the histone methyltransferase activity of Ash1 by sensing unmodified histone H3
Functional characterization of histone modifications : survey of novel histone modifications reveals PCMT1 as a new histone methyltransferase
Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma
Histone methyltransferase SETDB1 regulates fetal hematopoiesis
Assay development and inhibitor optimization for the histone lysine methyltransferase KMT9
Histone methyltransferase SMYD2: ubiquitous regulator of disease
Histone methyltransferase and drug resistance in cancers
The histone methyltransferase DOT1L is required for DNA damage recognition and repair
A somatic role for the histone methyltransferase Setdb1 in endogenous retrovirus silencing
Structural insights into a novel histone methyltransferase - KMT9
Histone H3 lysine 4 methyltransferase is required for facultative heterochromatin at specific loci
The promise of Immuno-oncology: implications for defining the value of cancer treatment
Caf1 regulates the histone methyltransferase activity of Ash1 by sensing unmodified histone H3
Functional characterization of histone modifications : survey of novel histone modifications reveals PCMT1 as a new histone methyltransferase